JPWO2023114822A5 - - Google Patents

Info

Publication number
JPWO2023114822A5
JPWO2023114822A5 JP2024535921A JP2024535921A JPWO2023114822A5 JP WO2023114822 A5 JPWO2023114822 A5 JP WO2023114822A5 JP 2024535921 A JP2024535921 A JP 2024535921A JP 2024535921 A JP2024535921 A JP 2024535921A JP WO2023114822 A5 JPWO2023114822 A5 JP WO2023114822A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
halo
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501509A5 (https=
JP2025501509A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081519 external-priority patent/WO2023114822A1/en
Publication of JP2025501509A publication Critical patent/JP2025501509A/ja
Publication of JP2025501509A5 publication Critical patent/JP2025501509A5/ja
Publication of JPWO2023114822A5 publication Critical patent/JPWO2023114822A5/ja
Pending legal-status Critical Current

Links

JP2024535921A 2021-12-15 2022-12-14 Ｒｘｆｐ１受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ Pending JP2025501509A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289830P 2021-12-15 2021-12-15
US63/289,830 2021-12-15
PCT/US2022/081519 WO2023114822A1 (en) 2021-12-15 2022-12-14 Benzothiazole, benzoisoxazole and benzodioxole analogs as rxfp1 receptor agonists

Publications (3)

Publication Number Publication Date
JP2025501509A JP2025501509A (ja) 2025-01-22
JP2025501509A5 JP2025501509A5 (https=) 2025-12-18
JPWO2023114822A5 true JPWO2023114822A5 (https=) 2025-12-18

Family

ID=85278236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535921A Pending JP2025501509A (ja) 2021-12-15 2022-12-14 Ｒｘｆｐ１受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ

Country Status (6)

Country Link
US (1) US20250066344A1 (https=)
EP (1) EP4448500A1 (https=)
JP (1) JP2025501509A (https=)
KR (1) KR20240120745A (https=)
CN (1) CN118401502A (https=)
WO (1) WO2023114822A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106780A1 (en) * 2023-11-17 2025-05-22 Eli Lilly And Company Rxfp1 receptor agonists
WO2025235833A1 (en) * 2024-05-10 2025-11-13 Eli Lilly And Company Rxfp1 receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013165606A1 (en) * 2012-05-04 2013-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of the relaxin receptor 1
CN106316987B (zh) * 2015-07-03 2020-11-17 江苏恒瑞医药股份有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的应用
WO2019057969A1 (en) * 2017-09-22 2019-03-28 Johann Wolfgang Goethe-Universität DOUBLE AGONISTS OF FXR AND PPARδ, AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2021534106A5 (https=)
JPWO2023099592A5 (https=)
JP2021534108A5 (https=)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2004524308A5 (https=)
JPWO2019195124A5 (https=)
JP2021535112A5 (https=)
JP2007504128A5 (https=)
JPWO2020252589A5 (https=)
JPWO2023195529A5 (https=)
RU99127433A (ru) Эрголиновые производные и их применение в качестве антагонистов рецепторов соматостатина
JPWO2023114822A5 (https=)
JP2005515976A5 (https=)
JP2024522201A5 (https=)
JPWO2023077070A5 (https=)
JPWO2023077040A5 (https=)
JPWO2023114937A5 (https=)
JPWO2020033488A5 (https=)
JPWO2023114818A5 (https=)
JPWO2023114819A5 (https=)
JPWO2023072257A5 (https=)
JPWO2022020730A5 (https=)
JPWO2023072240A5 (https=)
JPWO2023076626A5 (https=)
RU97108129A (ru) Нитробензамиды, применимые в качестве антиаритмических средств